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Abstract Swine are the only livestock species that
produce both the second mammalian isoform of
gonadotropin-releasing hormone (GNRH2) and its
receptor (GNRHR2). Previously, we reported that
GNRH2 and GNRHR2 mediate LH-independent
testosterone secretion from porcine testes. To further
explore this ligand-receptor complex, a pig model with
reduced GNRHR2 expression was developed. Small
hairpin RNA sequences targeting porcine GNRHR2
were subcloned into a lentiviral-based vector, lentivi-
ral particles were generated and microinjected into the
perivitelline space of zygotes, and embryos were
transferred into a recipient. One GNRHR2 knockdown
(KD) female was born that subsequently produced 80
piglets from 6 litters with 46 hemizygous progeny
(57% transgenic). Hemizygous GNRHR2 KD
(n = 10) and littermate control (n = 7) males were
monitored at 40, 100, 150, 190, 225 and 300 days of
age; body weight and testis size were measured and
serum was isolated and assayed for testosterone and
luteinizing hormone (LH) concentrations. Body
weight of GNRHR2 KD boars was not different from
littermate controls (P = 0.14), but testes were smaller
(P\ 0.05; 331.8 vs. 374.8 cm3, respectively). Testos-
terone concentrations tended (P = 0.06) to be reduced
in GNRHR2 KD (1.6 ng/ml) compared to littermate
control (4.2 ng/ml) males, but LH levels were similar
(P = 0.47). The abundance of GNRHR2 mRNA was
reduced (P\ 0.001) by 69% in testicular tissue from
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mature GNRHR2 KD (n = 5) versus littermate con-
trol (n = 4) animals. These swine represent the first
genetically-engineered model to elucidate the function
of GNRH2 and its receptor in mammals.
Keywords GNRH2  GNRHR2  Porcine 
Transgenic  Testosterone  Testis  Gene knockdown 
shRNA
Introduction
Gonadotropin-releasing hormone (GNRH1; pGlu-
His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly) is well-re-
garded as the master regulator of reproduction in
mammals. A second GnRH isoform (GNRH2; pGlu-
His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly) has also
been identified in mammals (White et al. 1998).
Expression of GNRH2 is ubiquitous (Neill 2002) and
is most abundant in tissues outside of the brain (White
et al. 1998), suggesting a divergent role from GNRH1.
Indeed, GNRH2 is a poor stimulator of gonadotropin
release; GNRH2-induced secretion of luteinizing
hormone (LH) and follicle-stimulating hormone
(FSH) is about 10% that of GNRH1 (Millar et al.
1986).
A 7-transmembrane, G-protein-coupled receptor
specific for GNRH2 (GNRHR2) has also been iden-
tified in mammals (Millar et al. 2001; Neill et al.
2001). Interestingly, GNRH1 receptor (GNRHR) and
GNRHR2 are quite different; their homology is only
about 40% and GNRHR2 has an intracytoplasmic tail
which GNRHR lacks (Millar 2003). Like its ligand,
the GNRHR2 gene is also expressed ubiquitously,
including extra-pituitary reproductive tissues (Millar
et al. 2001; Neill et al. 2001). Interestingly, GNRHR2
mRNA levels were highest in the marmoset testis
compared to 31 other organs (Millar et al. 2001).
However, most mammalian species are unable to
produce a functional GNRHR2 due to gene deletions
or gene coding errors (Gault et al. 2004; Millar 2003;
Morgan et al. 2003; Neill et al. 2002a; Pawson et al.
2003). In fact, the pig is the only livestock species to
maintain the appropriate sequence to encode a full-
length GNRHR2 (Stewart et al. 2009). Furthermore,
this receptor is considered functional since exogenous
GNRH2 treatment stimulated inositol triphosphate
production from COS cells overexpressing the porcine
GNRHR2 (Neill et al. 2002b).
Studies in boars indirectly suggested that a testic-
ular GnRH isoform mediates steroidogenesis within
the porcine testis (Bowen et al. 2006; Wise et al. 2000;
Zanella et al. 2000). However, GNRHR is absent in
swine testes (Zanella et al. 2000); therefore, we
hypothesized that the results of the aforementioned
studies could be ascribed to GNRHR2. In support of
this hypothesis, the GNRHR2 gene promoter is active
in a swine testis-derived (ST) cell line (Brauer et al.
2016) and both GNRH2 and GNRHR2 protein are
abundantly produced within the boar testis (De-
saulniers et al. 2015). We also demonstrated that
GNRHR2 immunolocalized to porcine Leydig cells
and exogenous GNRH2 treatment stimulated LH-
independent testosterone secretion from testes of boars
(Desaulniers et al. 2015). These data suggest that
swine maintain a unique testicular GNRH2-GNRHR2
system capable of regulating testosterone secretion in
a paracrine manner that is independent from the
classical androgen stimulator, LH. However, the
function and cellular mechanisms of GNRH2-medi-
ated testosterone secretion remain unknown. Thus, we
developed a GNRHR2 knockdown (KD) swine line to
further examine the role of GNRH2 and its receptor in
the boar testis.
Materials and methods
Animals
White crossbred pigs from the University of Nebraska-
Lincoln (UNL) Agricultural Research and Develop-
ment Center (ARDC) swine unit (Mead, NE) were
used to generate the founder animal. Yorkshire boar
semen, purchased from Swine Genetics International
(Cambridge, IA), was used to produce progeny from
the founder female. Farrowing and subsequent hous-
ing occurred within the UNLAnimal Science Building
(Lincoln, NE). Pre-pubertal pigs were group housed
with ad libitum access to feed and water. Adult pigs
were housed individually with ad libitum access to
water and fed approximately 2.5 kg of feed daily. All
diets were formulated to meet National Research
Council guidelines for each stage of production.
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Vector preparation, production of lentiviral
particles and ST cell transduction
Utilizing oligomer design software (Clontech, Moun-
tain View, CA), two potential target small hairpin
(shRNA) sequences, shRNA1 (TGGCTACT-
CAGTTTCCTTC) and shRNA2 (CTGTCATGAC-
CATCTGCTA), specific to the porcine GNRHR2
(NCBI accession number NM_001001639.2) were
identified and subcloned into a lentiviral-based,
pLVX-shRNA2 vector (Cat # 632179; Clontech) that
provides both ubiquitous shRNA and fluorescent
ZsGreen1 co-expression. Neither shRNA sequences
matched other genes in the porcine genome including
GNRHR (NCBI accession number JN120792.1). The
shRNA expression was driven by the human U6
promoter, whereas ZsGreen1 expression was con-
trolled by the cytomegalovirus (CMV) promoter.
Lentiviral particles were produced from each shRNA
vector, as well as a control vector, by transfection with
Fugene6 (Promega, Madison, WI) and the Lenti-X
HTX Packaging Mix into Lenti-X 293T cells
(Clontech). Briefly, 4 9 106 cells were plated in
10 cm dishes at approximately 70% confluency, and
cells were transfected with 5 lg of vector, 15 ll of
Lenti-X HTX Packaging Mix (Clontech) and 30 ll
Fugene6 (Promega). Approximately 48 h later, par-
ticles were harvested and concentrated (100X) with
Lenti-X Concentrator (Clontech) according to the
manufacturer’s instructions. Titrations of viral par-
ticles were performed by infecting swine testis-
derived (ST) cells (CRL-1746; ATCC, Manassas,
VA) with serial dilutions of lentivirus and counting
fluorescent cells to determine infectious units (IU)/
ml.
The ability of shRNA1 and shRNA2 lentiviral
particles to ablate porcineGNRHR2mRNA levels was
tested in ST cells. The day prior to transduction, ST
cells (1.2 9 106 cells/plate) were plated in 100 mm
plates containing high-glucose Dulbecco’s Modified
Eagle’s Medium (Mediatech, Herndon, VA) supple-
mented with 10% FBS, 2 mM glutamine, 100 U/ml
penicillin, and 100 lg/ml streptomycin sulfate (Gibco,
Grand Island, NY). Cells were transduced with
1.44 9 107 viral particles per plate for 48 h. At 48 h
post-transduction, RNA was isolated from ST cells
with TRIzol (1.5 ml/plate; Invitrogen, Grand Island,
NY) per manufacturer’s instructions and stored at
-20 C until reverse transcription (RT).
Quantitative PCR
Ribonucleic acid fromST cells wasDNase treatedwith
RQ1 (Promega) and quantitated using a Nanodrop
spectrophotometer (NanoDrop Technologies, Inc.,
Wilmington, DE). The RNA was reverse transcribed
into cDNA with M-MLV (Promega) and random
hexamers (Promega). The PCR amplification of
GNRHR2 was performed using forward (F-CCCCG
GACAAGGAAGGG) and reverse (R-AAGGAGCG
ACGGAGGGTCAA) primers (Integrated DNA Tech-
nologies, Coralville, Iowa) as well as a FAM labeled
TaqMan MGB probe (ATGATGCCCCTGCCGG;
Applied Biosystems, Foster City, CA). Quantitative
PCR was performed on cDNA samples with an ABI
7900 HT instrument (Applied Biosystems). The
amplification protocol included an initial 50 C step
for 2 min followed by 95 C for 10 min and then
alternating temperatures between 95 C for 15 s and
60 C for 1 min, repeated 50 times. The housekeeping
gene was eukaryotic RNA18S (kit #4319413E; VIC/
MGB Probe; Applied Biosystems). Cycling conditions
for RNA18S were the same as those described for
GNRHR2. Internal controls included samples prepared
without reverse transcriptase (no RT control) and
without cDNA (water only control).
Generation of transgenic pigs
RNA interference (RNAi) has successfully been
employed to impair gene expression in a variety of
mammalian cells (Dann 2007; Park 2007; Roelz et al.
2010; Rubinson et al. 2003). Transducing zygotes via
viral particles has generated transgenic mice (Miao
et al. 2011; Rubinson et al. 2003), rats (Dann 2007),
chickens (McGrew et al. 2004), goats (Golding et al.
2006) and pigs (Hofmann et al. 2003; Whitelaw et al.
2004). In this study, we utilized lentiviral particles and
RNAi to produce a transgenic model to study the
function of GNRHR2 in swine. Briefly, zygotes
(n = 50) were surgically flushed from the oviduct of
one superovulated, white crossbred donor sow.
Embryos were collected in Beltsville embryo culture
medium (BECM; 19.3 mM sodium lactate, 2.13 mM
calcium lactate, 90 mM sodium chloride, 4.83 mM
potassium chloride, 0.54 mM magnesium chloride,
2.14 mM sodium bicarbonate, 10.91 mM Hepes free
acid, 0.55 mM glucose, 11 mM mannitol, 1 mM L-
glutamine, 7 mM taurine, 0.27 mM sodium pyruvate,
Transgenic Res (2017) 26:567–575 569
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80 mM EDTA free acid, 0.001% phenol red, 1% BSA,
50 lg gentamycin sulfate; Dobrinsky et al. 1996) and
cultured briefly (1 h) prior to microinjection. All
reagents for BECM were purchased from Sigma (St.
Louis,MO) except L-glutamine, EDTA and gentamycin
sulfate (Gibco). Embryos were microinjected with
lentiviral particles according to a protocol generously
shared by Dr. Charles Long (Texas A&M University,
College Station, TX). Briefly, embryos were placed in
100 ll microdrops of BECM ? 200 mM sucrose
(Fisher, Fair Lawn, NJ) on micromanipulation plates
(100 9 15 mm petri dish; VWR International, Batavia,
IL) layered with embryo-tested mineral oil (M8410;
Sigma). Sucrose was utilized to retract the cytoplasm
from the zona pellucida to facilitate microinjection into
the perivitelline space (Miao et al. 2011). Using a
holding pipet (VacuTip; ID = 15 lm; OD = 100 lm;
Eppendorf, AF, Hamburg, Germany) and an intracyto-
plasmic sperm injection (ICSI) needle (TransferTip-F;
ID = 4 lm;OD = 7 lm; Eppendorf) backloaded with
5 ll of lentiviral particles (1.15 9 109 IU/ml), each
embryowasmicroinjectedwithin the perivitelline space
for 30 s using the manual setting (pi = 150 hPa;
pf = 0 hPa) on the Eppendorf Femtojet injection
system with a Nikon diaphot inverted micro-
scope (Melville, NY). A total of 40 microinjected
zygotes were surgically transferred into the oviduct of
one synchronized recipient female, which was allowed
to gestate to term.
Confirmation of transgene integration
Upon birth of piglets from the recipient, expression of
ZsGreen1 was examined with a UV light and a
Roscolux #15 (deep straw; Rosco, Port Chester, NY)
filter. In addition, genomic DNAwas isolated from tail
samples using aDNeasyBlood andTissueKit (Qiagen,
Valencia, CA). Transgene integration was evaluated
via conventional PCR using primers designed to
amplify a portion of the human U6 promoter driving
the shRNA (F-GAGGGCCTATTTCCCATGAT; R-G
ATCCTCGTCCTTTCCACAA), a region from the U6
promoter to the multiple cloning site (U6/MCS) to
verify incorporation of the shRNA sequence (F- GA
GGGCCTATTTCCCATGAT; R-GGGCGTACTTG
GCATATGAT), and a portion of the ZsGreen1 coding
sequence (F-CTGCATGTACCACGAGTCCA; R-GT
CAGCTTGTGCTGGATGAA). The Philisa Thermo-
cycler (Streck Inc., Omaha, NE) was used for rapid
evaluation of sampleswith the following conditions for
both the U6 and ZsGreen1 reactions: 1 X TaqBuffer A
(Fisher) with a final concentration of 3.0 mM MgCl2,
200 lM dNTPs, 400 nM of each primer and 1.25 U of
Taq DNA Polymerase (Fisher). Cycling conditions
were 95 C for 60 s, followed by 35 cycles of 95 C for
5 s, 55 C for 5 s and 72 C for 10 s and a final
extension of 72 C for 20 s. The U6/MCS PCR
reaction conditions were the same, however the
cycling conditions were as follows: 95 C for 60 s,
followed by 35 cycles of 95 C for 10 s, 56 C for 10 s
and 72 C for 15 s and a final extension of 72 C for
30 s. The resultant PCR products were subjected to
electrophoresis on a 1% agarose gel.
Inverse PCR was performed as described previ-
ously (Cederberg et al. 2015) to determine the location
and number of integration sites. Briefly, genomic
DNAwas digested with XbaI orHindIII and fragments
were self-ligated with a high concentration of T4 DNA
ligase (0.1 IU/ll; Thermo Scientific Fermentas, Pitts-
burg, PA) and a low concentration (2 lg/ll) of DNA.
PCR was performed on the circularized DNA with
primers selected from the integrated pLVX-shRNA2
sequence (XbaI-F: GAGATCCCTCAGACCCTTTT,
XbaI-R: GTTGCGTCAGCAAACACAGT; HindIII-
F: GAGCCCTCAGATCCTGCATA, HindIII-R: AG
CACCATCCAAAGGTCAGT) and in reverse orien-
tation of typical primers. Resultant PCR products were
sequenced with nested primers for XbaI (TCCCTCA-
GACCCTTTTAGTCA) and HindIII (CTGGCC
CTGGTGTGTAGTTC) derived products at the
University of Nebraska Medical Center Genomic
Core Facility (Omaha, NE).
Characterization of GNRHR2 KD swine line
At 40, 100, 150, 190, 225 and 300 days of age, testis
size of GNRHR2 KD (n = 10) and littermate control
(n = 7) boars was measured using digital calipers.
Predicted testis volume was calculated using the
following equation: Volume = 3/4(p)(L/2)(W/2)2,
where L = testis length and W = testis width (Bailey
et al. 1998). Body weight was recorded and blood
samples were collected via jugular venipuncture.
Blood samples were allowed to clot at 4 C overnight
before centrifugation (2000 9 g). Serum was col-
lected and stored at -20 C until use. Transgenic
(n = 5) and littermate control boars (n = 4) were
subsequently euthanized (717 ± 24 days of age) by
570 Transgenic Res (2017) 26:567–575
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intravenous injection of Fatal-Plus Solution (1 mg/
4.5 kg; pentobarbital; Vortech Pharmaceuticals, Dear-
born, MI). Testicular tissue was collected immediately
and stored in RNAlater (100 mg/ml; Qiagen) at
-20 C for subsequent mRNA analysis.
Radioimmunoassay
Unextracted serum was analyzed in duplicate to
quantify concentrations of testosterone by a double
antibody radioimmunoassay (RIA) kit (cat #
07-189102; MP Biomedicals, Aurora, OH), in accor-
dance with manufacturer’s instructions. Additional
standards (0.03 and 0.16 ng/ml) were added to reach
the sensitivity of the assay (0.03 ng/ml). The intra- and
inter-assay coefficients of variation (CV) were 6.5 and
7.7%, respectively. Concentrations of LH were deter-
mined by RIA at the Colorado State University
Reproductive Endocrinology Laboratory (Fort Col-
lins, CO). The intra- and inter-assay CV were 2.7 and
6.2%, respectively.
Digital droplet PCR
Digital droplet PCR (ddPCR) was used to quantify the
abundance of GNRHR2 mRNA in testes of transgenic
(n = 5) and control (n = 4) boars. Samples were
removed from RNAlater and homogenized in TRIzol
(1 ml; Invitrogen) with a Tissue Tearor (Biospec
Products Inc., Bartlesville, OK). Total RNA was
subsequently extracted using standard procedures with
chloroform and isopropyl alcohol. Ribonucleic acid
was DNAse treated, quantitated on a Nanodrop
spectrophotometer (NanoDrop Technologies, Inc.)
and reverse transcribed (2 ug) into cDNA as described
above.
To quantify GNRHR2 transcript levels, specific
primers (Integrated DNA Technologies) and a FAM
labeled TaqMan MGB probe (Applied Biosystems)
were utilized as described above. Each reaction
contained 1 ll of the cDNA template (undiluted),
900 nM of each primer, 250 nM of the probe and
ddPCR Supermix for Probes (Bio-Rad, Richmond,
CA). Droplets were generated using the QX200
Droplet Generator (Bio-Rad) according to manufac-
turer’s instructions. A C1000 Touch Thermal Cycler
(Bio-Rad) was utilized with the following conditions:
95 C for 5 min (enzyme activation), 95 C for 30 s
(denaturation) followed by 60 C for 1 min
(annealing/extension; 40 cycles), 4 C for 5 min and
90 C for 5 min (signal stabilization). Droplets were
read via the QX200 droplet reader (Bio-Rad) and
analyzed using Quantasoft Software (Bio-Rad). The
housekeeping gene utilized was ACTB; each reaction
contained 1 ll of the cDNA template (diluted 1:100),
100 nM of each primer (F-AACTCCATCAT-
GAAGTGCGACG; R-GATCCACATCTGCTG-
GAAGG) and EvaGreen ddPCR Supermix (Bio-
Rad). Cycling conditions for ACTB were the same as
those described for GNRHR2 reactions.
Statistical analysis
Statistical analyses were performed using the Statis-
tical Analysis System (SAS; Cary, NC). The mRNA
data was analyzed using theMIXED procedure of SAS
with lentiviral treatment or swine line included in the
model as the fixed effect. When applicable, litter was
included in the model as a random effect. The
experimental unit was either plate or animal. When a
significant treatment effect (P B 0.05) was observed,
pair-wise comparisons were made using the Tukey-
Kramer test.
Hormone data, predicted testis volume and body
weightwere analyzed via theMIXEDprocedure of SAS
using a model that included line (transgenic or control),
age (days), and their interaction as fixed effects. Animal
was the experimental unit and litter was included as a
random effect. Age was used as the repeated measure
with animal as the subject. Degrees of freedom for the
pooled error term were calculated using the Satterth-
waite approximation. Based on the Akaike’s informa-
tion criterion, a heterogeneous autoregressive function
with lag equal to 1 was used to model the covariance
structure for the repeated measures. When analyzing
predicted testis volume, body weight was found to be a
significant covariable (P = 0.02) and therefore was
included in the statistical model. In contrast, predicted
testis volume was not found to be a significant
covariable for testosterone concentration, therefore it
was excluded from the analysis. A single LH value
(control boar; 150 days of age) was found to be an
outlier (± 2 standard deviations from the mean) so it
was excluded from the dataset. AP value ofB 0.05was
considered significant, whereas aP value ofB 0.10was
considered a tendency. Results are presented as least
squaresmeans (LSMEANS) ± the standard error of the
mean (SEM).
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Results and discussion
Previously, our laboratory detected GNRHR2 protein
within the swine testis (Desaulniers et al. 2015) as well
as the ST cell line (data not shown). Therefore, we
transduced ST cells with lentiviral particles derived
from a vector (Fig. 1a) overexpressing shRNA speci-
fic to the GNRHR2 (shRNA1 and shRNA2) in order to
test the efficacy of lentiviral particles prior to produc-
tion of a transgenic pig line. Lentiviral particles
containing either shRNA1 or shRNA2 sequences
significantly reduced GNRHR2 mRNA levels (95
and 99%, respectively) compared to control particles
(P\ 0.05; Fig. 1b). After the efficiency of the
lentiviral particles was confirmed in vitro, lentiviral
particles derived from the vector overexpressing
shRNA2 were microinjected into porcine zygotes
before transfer into a synchronized recipient female.
The recipient gestated for 113 days and farrowed 5
healthy, live piglets (2 males and 3 females). One
female exhibited ZsGreen1 fluorescence of the skin
(20% efficiency), indicative of successful transgene
integration and expression. Transgene integration was
confirmed via conventional PCR using primers
designed to amplify the human U6 promoter driving
the shRNA, ZsGreen1, and a region from the U6
promoter to the multiple cloning site (U6/MCS) to
verify incorporation of the shRNA sequence (Fig. 1c).
Sequence analysis of products from inverse PCR
procedures revealed that a single integration site was
present on chromosome 14, aligning with clone
NW_003612067.1 with 99% identity and matching
identities 448,946-448,372. Thus, the transgene inte-
grated in a non-coding region between the Sorbin and
SH3 Domain Containing 1 (SORBS1) and the Alde-
hyde Dehydrogenase 18 Family, Member A1
(ALDH18A1) genes (Fig. 1d). This animal was
retained to generate the GNRHR2 KD swine line.
The founder gilt was bred at her third post-pubertal
estrus to a commercial white crossbred boar and
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Fig. 1 Generation of GNRHR2 KD pigs. a Schematic repre-
sentation of the construct used for lentiviral particle generation.
b GNRHR2 mRNA levels in ST cells following transduction
with lentiviral particles containing shRNA specific for the
GNRHR2 or control. Data are presented as the LSMEANS ±
SEM. *P\ 0.05. c PCR detection of GNRHR2 KD founder
(#1001) and control littermates (#1–4). M, DNA ladder; ?,
positive plasmid control; -, negative control. d Sequencing
analysis of inverse PCR products revealed that a single
integration site was present on chromosome 14, located between
the Sorbin and SH3 Domain Containing 1 (SORBS1) and the
Aldehyde Dehydrogenase 18 Family, Member A1 (ALDH18A1)
genes
572 Transgenic Res (2017) 26:567–575
123
subsequently gestated to term. She farrowed 15
healthy piglets with 5 progeny exhibiting ZsGreen1
expression (3 males and 2 females). The founder
female subsequently produced a total of 80 piglets
from 6 litters (6 different white crossbred sires) with
46 transgenic piglets (57%), confirming germline
transmission of the transgene and providing further
evidence for a single integration site.
During pubertal development, hemizygous
GNRHR2 KD (n = 10) and littermate control
(n = 7) boars from 4 litters were monitored for
differences in body weight, predicted testis volume
and serum hormone (testosterone and LH) concentra-
tions. Body weight was not affected by line
(P = 0.14) or line by age interaction (P = 0.61),
indicating that GNRHR2 KD and littermate control
boars had a similar body weight during pubertal
development (Fig. 2a). Despite a similar body weight,
there was a line effect (P\ 0.05) for predicted testis
volume. Predicted testis volume of GNRHR2 KD
boars was smaller (331.77 ± 13.9 cm3) overall during
pubertal development than for littermate controls
(374.75 ± 17.17 cm3; Fig. 2b), suggesting a defect
in testis development. As expected, there was an effect
of age on predicted testis volume (P\ 0.0001) but
there was no line by age interaction (P = 0.39;
Fig. 2b).
There was no line by age interaction (P = 0.39;
Fig. 2c) on concentration of testosterone in serum.
However, there was a tendency for a line effect
(P = 0.06; Fig. 2c) as well as an expected effect of
age (P\ 0.0001; Fig. 2c). GNRHR2 KD boars tended
to have reduced concentrations of testosterone in
serum overall during pubertal development
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Fig. 2 GNRHR2 KD swine (n = 10) have smaller testes and
reduced serum testosterone concentrations compared to litter-
mate control (n = 7) animals during pubertal development. At
40, 100, 150, 190, 225 and 300 days of age, blood was collected
and body weight and predicted testis volume were determined.
Serum testosterone and LH concentrations were determined by
radioimmunoassay. Data are presented as the
LSMEANS ± SEM. a Body weight: Line, P = 0.14; Time,
P\ 0.0001; Line 9 Time, P = 0.61. Predicted testis volume
(b): Line, P = 0.05; Time, P\ 0.0001; Line 9 Time,
P = 0.39. Testosterone (c), Line, P = 0.06; Time,
P\ 0.0001; Line 9 Time, P = 0.39. Luteinizing hormone
(d), Line, P = 0.47; Time, P\ 0.0001; Line 9 Time,
P = 0.52
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(1.63 ± 0.87 ng/ml) compared with littermate control
animals (4.18 ± 1.0 ng/ml; P = 0.06). Despite dif-
ferences in testosterone secretion, LH concentrations
were similar between GNRHR2 KD and control boars
during development (P = 0.47; Fig. 2d). To confirm
knockdown in these animals, transgenic (n = 5) and
control (n = 4) testicular tissue was collected and
GNRHR2 mRNA abundance was determined via
ddPCR. Testicular GNRHR2 mRNA levels in trans-
genic boars were approximately 69% less than litter-
mate control boars (P\ 0.001; Fig. 3), confirming the
successful production of a GNRHR2 KD swine line.
These findings are consistent with our previous report
demonstrating that GNRH2 stimulates testosterone
secretion in vivo, without the classic preceding rise in
serum LH levels associated with GNRH1 (Desaulniers
et al. 2015) and strengthen our hypothesis that
GNRHR2 is involved in testicular steroidogenesis
within swine testes. However, since LH and testos-
terone are released in a pulsatile manner, it will be
prudent to collect serial blood samples as well.
In conclusion, these swine represent the first
genetically-engineered animal model to unravel the
biological function of GNRH2 and its receptor in
mammals. During pubertal development, GNRHR2
KD boars had smaller testes despite similar body
weights. Transgenic males also tended to have reduced
serum testosterone concentrations, independent of
alterations in circulating LH levels. These results
indicate that GNRHR2 is directly involved in the
regulation of testicular steroidogenesis in swine. This
animal model will be used in future studies to
elucidate the cellular mechanisms associated with
localized regulation of testosterone secretion and
define what consequences it may have for fertility in
pigs.
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